ScholarIQanswers from OpenAlex

Adalimumab Induces Deep Remission in Patients With Crohn's Disease

PaperCitations, authors & open-access status

Adalimumab Induces Deep Remission in Patients With Crohn's Disease is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Adalimumab Induces Deep Remission in Patients With Crohn's Disease have?

ScholarIQcitation count

Adalimumab Induces Deep Remission in Patients With Crohn's Disease has 248 citations in the OpenAlex counts ScholarIQ stores.

When was Adalimumab Induces Deep Remission in Patients With Crohn's Disease published?

ScholarIQyear

Adalimumab Induces Deep Remission in Patients With Crohn's Disease has 2013 year in the ScholarIQ index.

What is the open-access status of Adalimumab Induces Deep Remission in Patients With Crohn's Disease?

ScholarIQoa status

Adalimumab Induces Deep Remission in Patients With Crohn's Disease has closed oa status in the ScholarIQ index.

What is the DOI of Adalimumab Induces Deep Remission in Patients With Crohn's Disease?

ScholarIQdoi

The DOI for Adalimumab Induces Deep Remission in Patients With Crohn's Disease is on the source record.

What is the PMID of Adalimumab Induces Deep Remission in Patients With Crohn's Disease?

ScholarIQpmid

The PMID for Adalimumab Induces Deep Remission in Patients With Crohn's Disease is on the source record.

What is the OpenAlex record for Adalimumab Induces Deep Remission in Patients With Crohn's Disease?

ScholarIQopenalex

The OpenAlex for Adalimumab Induces Deep Remission in Patients With Crohn's Disease is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial